ND0612, a novel liquid formulation of levodopa/carbidopa for subcutaneous infusion in patients with Parkinson's disease achieves stable levodopa plasma levels when administered in low and high doses

被引：0
|
作者：
Giladi, Nir [1 ]
Caraco, Yoseph [2 ]
Gurevich, Tanya [3 ]
Djaldetti, Ruth [4 ]
Adar, Liat [5 ]
Cohen, Yael [5 ]
Minei, Tamar Rachmilewitz [5 ]
Oren, Sheila [5 ]
机构：
[1] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[2] Hadassah Med Ctr, Jerusalem, Israel
[3] Sackler Sch Med, Tel Aviv, Israel
[4] Tel Aviv Univ, Petah Tiqwa, Israel
[5] NeuroDerm Ltd, Rehovot, Israel
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S4.002
引用
收藏
页数：3
相关论文
共 39 条
  • [21] Foslevodopa/foscarbidopa maintains stable levodopa and carbidopa exposure following subcutaneous infusion in Parkinson's disease patients
    Rosebraugh, M.
    Liu, W.
    Facheris, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 662 - 662
  • [22] Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study
    Ellenbogen, Aaron L.
    Poewe, Werner
    Espay, Alberto J.
    Simuni, Tanya
    Gurevich, Tanya
    Yardeni, Tami
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Stocchi, Fabrizio
    BeyoND Study Grp
    PARKINSONISM & RELATED DISORDERS, 2025, 132
  • [23] BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease experiencing motor complications
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Adar, L.
    Rosenfeld, O.
    Olanow, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1105 - 1105
  • [24] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05): : 465 - 476
  • [25] Constant therapeutic levodopa (LD) plasma concentrations maintained by continuous subcutaneous (SC) administration of ND-0612, a novel formulation of LD/carbidopa (CD)
    Caraco, Y.
    Oren, S.
    LeWitt, P.
    MOVEMENT DISORDERS, 2013, 28 : S162 - S162
  • [26] Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels
    Kulisevsky, J
    Avila, A
    Barbanoj, M
    Antonijoan, R
    Berthier, ML
    Gironell, A
    BRAIN, 1996, 119 : 2121 - 2132
  • [27] Switch from levodopa/carbidopa to the corresponding Stalevo dosage improves motor symptoms and elevates levodopa plasma levels in patients with Parkinson's disease
    Müller, T
    Erdmann, C
    Muhlack, S
    Bremen, D
    Przuntek, H
    Woitalla, D
    MOVEMENT DISORDERS, 2005, 20 : S46 - S46
  • [28] ABBV-951 Maintains Stable Levodopa Exposure following Subcutaneous Infusion in Parkinson's Disease Patients
    Rosebraugh, Matthew
    Kym, Philip
    Liu, Wei
    Facheris, Maurizio
    NEUROLOGY, 2020, 94 (15)
  • [29] Reducing Dosing Frequency of Carbidopa/Levodopa: Double-Blind Crossover Study Comparing Twice-Daily Bilayer Formulation of Carbidopa/Levodopa (IPX054) Versus 4 Daily Doses of Standard Carbidopa/Levodopa in Stable Parkinson Disease Patients
    Hinson, Vanessa K.
    Goetz, Christopher G.
    Leurgans, Sue
    Fan, Wenqing
    Nguyen, Tiffany
    Hsu, Ann
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (04) : 189 - 192
  • [30] A Novel Levodopa/Carbidopa Prodrug (ABBV-951) 24-Hour Continuous Subcutaneous Infusion Treatment for Parkinson's Disease
    Rosebraugh, Matthew
    Kym, Philip
    Liu, Wei
    Facheris, Maurizio
    Benesh, Janet
    NEUROLOGY, 2019, 92 (15)
1234